Adi Diab

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 28 papers. Top paper: “Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity”.

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Cancer Cell(2022)10.1016/j.ccell.2022.04.004

N/A

4.7DataRank · unranked

350 citations

Daniel H. Johnson, Noha Abdel‐Wahab, Wai Chin Foo, Salah-Eddine Bentebibel, May Daher +32 more

Concurrent intrathecal and intravenous nivolumab in leptomeningeal disease: phase 1 trial interim results

Nature Medicine(2023)10.1038/s41591-022-02170-x

N/A

1.9DataRank · unranked

83 citations

Sherise D. Ferguson, Roland L. Bassett, Alexandra P. Foster, Ida John, Tarin Hennegan +32 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2021)10.1016/j.ccell.2020.11.015

N/A

1.9DataRank · unranked

53 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodriguez, Petra Ross-Macdonald, Megan Wind-Rotolo +31 more

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Science(2018)10.1126/science.aan4236

N/A

1.3DataRank · unranked

4585 citations

C. N. Spencer, Luigi Nezi, Alexandre Reuben, Miles C. Andrews, Tatiana V. Karpinets +89 more

Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/− trastuzumab in patients with breast cancer brain metastases

npj Breast Cancer(2022)10.1038/s41523-022-00404-2

N/A

0.996DataRank · unranked

31 citations

Kathryn Beal, Stefanie N. Linch, Kateri J. Spinelli, Micaela Rodine, Darragh Halpenny +12 more

Cutaneous adverse events in 155 patients with metastatic melanoma consecutively treated with anti‐CTLA4 and anti‐PD1 combination immunotherapy: Incidence, management, and clinical benefit

Cancer(2021)10.1002/cncr.34004

N/A

0.890DataRank · unranked

21 citations

Sahira Farooq, Macartney Welborn, Rodabe N. Amaria, Susan Y. Chon, Adi Diab +13 more

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2022)10.1038/s41586-022-05368-8

N/A

0.874DataRank · unranked

339 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications

Frontiers in Immunology(2021)10.3389/fimmu.2020.590494

N/A

0DataRank · unranked

43 citations

Ajay Sheshadri, Vickie R. Shannon, Dimitrios P. Kontoyiannis, Hagop M. Kantarjian, Guillermo Garcia‐Manero +20 more

Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist

Nature Communications(2020)10.1038/s41467-019-12901-3

N/A

0DataRank · unranked

95 citations

Justin D. Saco, Felix B. Salazar, Jennifer Tsoi, Paige Krystofinski, Cristina Puig-Saus +16 more

Distinct molecular and immune hallmarks of inflammatory arthritis induced by immune checkpoint inhibitors for cancer therapy

Nature Communications(2022)10.1038/s41467-022-29539-3

N/A

0DataRank · unranked

117 citations

Yanshuo Chu, Mercy Misoi, María E. Suarez‐Almazor, Jean Tayar, Huifang Lu +33 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

The Journal of Experimental Medicine(2022)10.1084/jem.20221333

N/A

0DataRank · unranked

64 citations

Yusra B. Medik, Bhakti Patel, Daniel Zamler, Sijie Chen, Thomas Chapman +39 more

LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade

Journal of Clinical Investigation(2022)10.1172/jci154152

N/A

0DataRank · unranked

44 citations

Joost Koetsier, Trevin Kurtanich, Michael Engelbrecht Nielsen, Glenn Winn, Yunfei Wang +25 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005

N/A

0DataRank · unranked

389 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more

B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade

Frontiers in Immunology(2022)10.3389/fimmu.2022.794684

N/A

0DataRank · unranked

23 citations

Jason Roszik, Neeraj K. Saini, Vipul Kumar Singh, Karishma Bavisi, Zhiqiang Wang +11 more

Genomic Correlates of Outcome in Tumor-Infiltrating Lymphocyte Therapy for Metastatic Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-1060

N/A

0DataRank · unranked

17 citations

Yuzhong Jeff Meng, Marie‐Andrée Forget, Tatiana V. Karpinets, Katarzyna Tomczak, Chip Stewart +22 more

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

(2022)10.52519/00101

N/A

0DataRank · unranked

3 citations

Yusra B. Medik, Bhakti K. Patel, Daniel B. Zamler, Sijie Chen, T. Chapman +39 more

Immune-related adverse events and symptom burden in patients with melanoma receiving adjuvant immune checkpoint inhibitor.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps12147

N/A

0DataRank · unranked

0 citations

Teresa Kuś, Salah-Eddine Bentebibel, Jennifer L. McQuade, Isabella Claudia Glitza, Rodabe N. Amaria +11 more

Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000537

N/A

0DataRank · unranked

216 citations

Rishab Ramapriyan, Ahmed Younes, Mauricio S. Caetano, Hari Menon, Nathan Comeaux +16 more

Safety and effectiveness of combination versus monotherapy with immune checkpoint inhibitors in patients with preexisting autoimmune diseases

OncoImmunology(2023)10.1080/2162402x.2023.2261264

N/A

0DataRank · unranked

8 citations

Sabina Sandigursky, Juhee Song, María A. López-Olivo, Houssein Safa, Samuel Cytryn +12 more

Physician Views on the Provision of Information on Immune Checkpoint Inhibitor Therapy to Patients with Cancer and Pre-Existing Autoimmune Disease: A Qualitative Study

Cancers(2023)10.3390/cancers15102690

N/A

0DataRank · unranked

6 citations

Gabrielle F. Duhon, Juan Ignacio Ruiz, Mehmet Altan, Hussein A. Tawbi, Adi Diab +6 more

Associations between KIR/KIR-ligand genotypes and clinical outcome for patients with advanced solid tumors receiving BEMPEG plus nivolumab combination therapy in the PIVOT-02 trial

Cancer Immunology Immunotherapy(2023)10.1007/s00262-023-03383-w

N/A

0DataRank · unranked

4 citations

Amy K. Erbe, Jennifer Birstler, KyungMann Kim, Ute Hoch, Sue Currie +8 more

Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma

Nature(2023)10.1038/s41586-023-05892-1

N/A

0DataRank · unranked

2 citations

Michael A. Postow, Elizabeth M. Burton, Michael T. Tetzlaff, Merrick I. Ross, Carlos A. Torres‐Cabala +35 more

Determinants of racial disparities in immune-related adverse events (irAE) with checkpoint inhibition (ICI) in melanoma.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.9549

N/A

0DataRank · unranked

0 citations

Paola Angulo, Faisal Fa’ak, Noha Abdel‐Wahab, Adi Diab, Janice M. Mehnert +6 more

910 Development and user testing of a website with information for cancer patients who have pre-existing autoimmune disease and are considering immune checkpoint inhibitors (ICIs)

Regular and Young Investigator Award Abstracts(2023)10.1136/jitc-2023-sitc2023.0910

N/A

0DataRank · unranked

0 citations

María E. Suarez‐Almazor, Gabrielle F. Duhon, McKenna Erck, Cassandra Calabrese, Mehmet Altan +7 more

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

OncoImmunology(2025)10.1080/2162402x.2025.2546402

N/A

0DataRank · unranked

5 citations

Simin Kiany, Marie‐Andrée Forget, Roland L. Bassett, Michael A. Davies, Adi Diab +15 more

Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade

Nature Medicine(2021)10.1038/s41591-021-01406-6

N/A

0DataRank · unranked

424 citations

Connie P. M. Duong, Vancheswaran Gopalakrishnan, Valerio Iebba, W. S. Chen, Lisa Derosa +66 more

Infliximab for Grade III or IV Immune Checkpoint Inhibitor Nephritis Clinical and Translational Evidence

Kidney International Reports(2025)10.1016/j.ekir.2025.10.018

N/A

0DataRank · unranked

0 citations

Masroor Habeeb, Hong Chen, Zainab Alhamal, Omar Mamlouk, Heather Lin +7 more

Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002449

N/A

0DataRank · unranked

44 citations

Rodabe N. Amaria, Amer Najjar, Laszlo Radvanyi, Cara Haymaker, Marie-Andrée Forget +18 more